GENEXPERT (XPERT MTB/RIF)

GeneXpert (Xpert MTB/RIF) is an advanced molecular diagnostic test designed for the rapid detection of Mycobacterium tuberculosis (MTB), the bacterium responsible for tuberculosis (TB), along with simultaneous identification of Rifampicin resistance. The test uses automated real-time PCR technology and provides highly accurate results within a short period, making it one of the most important tools for early TB diagnosis.

Tuberculosis remains a major public health concern worldwide. Early detection and identification of drug resistance are critical for initiating appropriate treatment, preventing disease transmission, and improving patient outcomes. GeneXpert testing is recommended by international and national TB control programs because of its high sensitivity and rapid turnaround time.

Benefits of the Test

• Rapid detection of Mycobacterium tuberculosis.
• Simultaneously detects Rifampicin resistance.
• Provides highly sensitive and specific molecular results.
• Supports early diagnosis of pulmonary and extrapulmonary TB.
• Reduces delays in treatment initiation.
• Helps identify drug-resistant tuberculosis.
• Automated testing minimizes human error.
• Supports effective TB control and patient management.

Why Doctors Recommend This Test

Doctors recommend GeneXpert MTB/RIF testing for patients with suspected tuberculosis, persistent cough, fever, weight loss, night sweats, abnormal chest imaging, suspected drug-resistant TB, HIV-associated TB, and extrapulmonary tuberculosis.

The test enables rapid diagnosis and early identification of Rifampicin resistance, helping clinicians choose appropriate treatment regimens.

Preparation Before Test

• No fasting is required.
• Sputum is the most commonly used sample for pulmonary TB evaluation.
• Other clinical specimens may be accepted for extrapulmonary TB testing.
• Follow specimen collection instructions carefully.
• Inform your doctor about previous TB treatment history.
• Provide relevant medical and travel history when applicable.

Normal Reporting Time

Most GeneXpert (Xpert MTB/RIF) reports at Focus Diagnostics are available within 2–3 hours after specimen processing and molecular workflow initiation. Final validated reporting may vary depending on laboratory protocols and specimen requirements.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected pulmonary tuberculosis.
• Individuals with persistent cough lasting more than two weeks.
• Patients with unexplained weight loss and fever.
• People with suspected drug-resistant TB.
• Individuals living with HIV/AIDS.
• Patients with abnormal chest X-ray findings.
• People with suspected extrapulmonary tuberculosis.
• Individuals requiring rapid TB diagnosis.

Detailed Information

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and primarily affects the lungs, although it can involve almost any organ in the body. Symptoms commonly include persistent cough, fever, night sweats, fatigue, chest pain, and weight loss. Early diagnosis is essential because untreated TB can lead to severe complications and ongoing transmission within the community.

Traditional TB diagnostic methods such as smear microscopy and culture have important limitations. Smear microscopy may miss cases with low bacterial loads, while culture testing, although highly sensitive, may require several weeks to provide results. GeneXpert technology addresses these limitations by providing rapid molecular detection of TB bacteria.

The Xpert MTB/RIF assay uses automated real-time Polymerase Chain Reaction (PCR) technology to detect genetic sequences specific to Mycobacterium tuberculosis. At the same time, the assay evaluates mutations associated with Rifampicin resistance, one of the most important markers of multidrug-resistant tuberculosis (MDR-TB).

The test is highly valuable for diagnosing TB in high-risk populations, including HIV-positive individuals, children, immunocompromised patients, and those with suspected drug-resistant disease. Rapid identification allows healthcare providers to initiate appropriate therapy sooner and implement infection control measures when necessary.

GeneXpert testing may be performed on sputum, bronchoalveolar lavage specimens, lymph node samples, cerebrospinal fluid, pleural fluid, and other appropriate clinical specimens depending on the suspected site of infection.

Results should always be interpreted alongside clinical findings, radiological investigations, microbiological studies, and physician evaluation. Additional culture and drug susceptibility testing may be recommended in certain situations.

At Focus Diagnostics, GeneXpert (Xpert MTB/RIF) testing is performed using advanced molecular diagnostic platforms, validated PCR technology, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful tuberculosis diagnostic results.